TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name |
City of registered office |
Country of registered office |
J.P. Morgan Securities plc |
|
|
5. Date on which the threshold was crossed or reached
09-Nov-2023
6. Date on which Issuer notified
13-Nov-2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|
Resulting situation on the date on which threshold was crossed or reached |
4.349485 |
3.354408 |
7.703893 |
8774131 |
Position of previous notification (if applicable) |
2.394554 |
5.093863 |
7.488417 |
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
GB0009633180 |
|
4953698 |
|
4.349485 |
Sub Total 8.A |
4953698 |
4.349485% |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
Sub Total 8.B1 |
|
|
|
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
Cash-settled Equity Swap |
20/02/2024 |
20/02/2024 |
Cash |
6220 |
0.005452 |
Cash-settled Equity Swap |
21/02/2024 |
21/02/2024 |
Cash |
689000 |
0.604961 |
Cash-settled Equity Swap |
04/03/2024 |
04/03/2024 |
Cash |
5090 |
0.004469 |
Cash-settled Equity Swap |
06/03/2024 |
06/03/2024 |
Cash |
1420344 |
1.247101 |
Cash-settled Equity Swap |
19/06/2024 |
19/06/2024 |
Cash |
1526 |
0.001339 |
Cash-settled Equity Swap |
27/06/2024 |
27/06/2024 |
Cash |
1783 |
0.001565 |
Cash-settled Equity Swap |
02/07/2024 |
02/07/2024 |
Cash |
3066 |
0.002687 |
Cash-settled Equity Swap |
12/07/2024 |
12/07/2024 |
Cash |
1390089 |
1.220537 |
Cash-settled Equity Swap |
31/07/2024 |
31/07/2024 |
Cash |
39012 |
0.034252 |
Cash-settled Equity Swap |
02/08/2024 |
02/08/2024 |
Cash |
531 |
0.000462 |
Cash-settled Equity Swap |
17/10/2024 |
17/10/2024 |
Cash |
174549 |
0.153257 |
Cash-settled Equity Swap |
04/11/2024 |
04/11/2024 |
Cash |
17 |
0.000014 |
Cash-settled Equity Swap |
07/11/2024 |
07/11/2024 |
Cash |
4122 |
0.003619 |
Cash-settled Equity Swap |
20/11/2024 |
20/11/2024 |
Cash |
10374 |
0.009102 |
Cash-settled Equity Swap |
03/12/2024 |
03/12/2024 |
Cash |
45107 |
0.039602 |
Cash-settled Equity Swap |
09/12/2024 |
09/12/2024 |
Cash |
6000 |
0.005268 |
Cash-settled Equity Swap |
16/01/2026 |
16/01/2026 |
Cash |
420 |
0.000368 |
Cash-settled Equity Swap |
10/06/2026 |
10/06/2026 |
Cash |
9625 |
0.008451 |
Cash-settled Equity Swap |
18/06/2027 |
18/06/2027 |
Cash |
6891 |
0.006050 |
Cash-settled Equity Swap |
30/05/2028 |
30/05/2028 |
Cash |
6667 |
0.005852 |
Sub Total 8.B2 |
|
3820433 |
3.354408% |
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
JPMorgan Chase & Co. |
J.P. Morgan Securities plc |
4.341025 |
3.354408 |
7.695433% |
JPMorgan Chase & Co. |
J.P. Morgan Securities LLC |
|
|
|
JPMorgan Chase & Co. |
J.P. Morgan SE |
|
|
|
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
12. Date of Completion
13-Nov-2023
13. Place Of Completion
London